With the anti-obesity pharmacotherapy landscape rapidly evolving, two investigational agents from Eli Lilly have recently demonstrated highly promising Phase 2 results: Retatrutide (LY3437943) and Eloralintide (LY3841136)
The monthly membership includes: A new-patient evaluation with a provider, including labs (A1C, lipids, comprehensive metabolic panel, TSH, when indicated) A prescription for FDA-approved semaglutide (Wegovy) or tirzepatide (Zepbound) when clinically appropriate, billed through your pharmacy or, when feasible, the manufacturer's direct-pay channel Monthly follow-up visits to track weight, blood pressure, side effects, and dose titration Adjustments to other medications (blood pressure, diabetes, lipids) as your numbers improve A clear plan for what happens if you plateau, if side effects become a problem, or if your insurance changes A maintenance plan for after you hit your goal weight We don't promise quick fixes, before-and-after photos, or a specific number on the scale
Its also important to remember that each person reacts to medications differently
Ayuda a relajar los vasos sanguneos y puede mejorar el flujo sanguneo
